#SARCLISA

Latest posts tagged with #SARCLISA on Bluesky

Trending

#Illinois Primaries #The Archers #European Politics #Trump's NATO Stance #US-Iran Relations #ICE Custody #Joe Kent #St. Patrick's Day #World Baseball Classic #Rachel Maddow #Illinois Primaries #The Archers #European Politics #Trump's NATO Stance #US-Iran Relations #ICE Custody #Joe Kent #St. Patrick's Day #World Baseball Classic #Rachel Maddow

Posts tagged #SARCLISA

@jyves94.bsky.social

7 months ago

Bonnes nouvelles sur le #MyélomeMultiple 🩸

Deux nouvelles thérapeutiques ont été approuvées dans l' #UE

#BLENREP ( #GSK) pour les patients atteints de #Myélome R/R

#SARCLISA ( #Sanofi) pour les patients nouvellement diagnostiqués & transplantables

myelom.online/multiples-my...

1 0 0 0

Profit Trading USA

@profittradingusa.bsky.social

7 months ago

Sanofi’s Sarclisa receives EU approval for newly diagnosed multiple myeloma Investing.com -- Sanofi SA (EPA:SASY) announced Friday that its drug Sarclisa has received approval in the European Union for the treatment of transplant-eligible newly diagnosed multiple myeloma. The approval extends Sarclisa’s use across all therapy lines in the EU, marking an important expansion of the drug’s treatment scope. According to the French pharmaceutical company, Sarclisa-VRD demonstrated a significant benefit in minimal residual disease (MRD) negativity, an important measure of treatment effectiveness in multiple myeloma patients. This regulatory milestone adds to Sarclisa’s existing approvals, now making it available for multiple myeloma patients at various stages of their treatment journey within the European Union. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is SASY one of them?

Click Subscribe #MultipleMyeloma #Sarclisa #CancerTreatment #Pharmaceuticals #EUApproval

0 0 0 0

@jyves94.bsky.social

1 year ago

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma Approval is based on positive...

Communiqué de presse #SANOFI : #Sarclisa approuvé dans l'#UE comme premier traitement anti-#CD38 en association avec le #VRd standard pour traiter le #MyélomeMultiple 🩸 nouvellement diagnostiqué et non éligible à la transplantation
www.sanofi.com/en/media-roo...

0 0 0 0